WeVote
Log In

Bill

Bill

HD 759

An Act relative to copay assistance

194th Legislature (2025-2026) Introduced by Brian Ashe and 1 co-sponsor

Massachusetts bill regulating copay assistance programs to establish transparency and operational standards for patient medication cost-sharing aid services.

0
WeVote Research Nonpartisan
Bill Summary · HD 759

Legislative bill overview

HD 759 would regulate copay assistance programs—services that help patients pay their out-of-pocket costs for medications and treatments. The bill likely establishes transparency requirements, limits on how these programs operate, or rules governing which patients can access them. These programs are often funded by pharmaceutical manufacturers or nonprofits but can create conflicts of interest in healthcare decision-making.

Why is this important

Copay assistance programs affect millions of patients' ability to afford medications, but they can also inflate drug prices by removing patient cost-sensitivity and enabling higher list prices. Regulating these programs could improve transparency for insurers and policymakers while potentially affecting patient access to expensive treatments. The balance between affordability and market dynamics makes this a significant healthcare policy issue.

Potential points of contention

  • Whether regulations expand or restrict patient access to copay assistance, affecting affordability for those with high out-of-pocket costs
  • Whether transparency requirements adequately address manufacturer incentives to promote higher-priced drugs over generic alternatives
  • How rules interact with insurance plan designs and whether they shift costs to employers, insurers, or patients in unintended ways

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.